Columbus, OH 的 腦瘤 臨床試驗
11 項針對 腦瘤 的研究正在 Columbus（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- Ohio State University, Columbus
SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
招募中1/2 期
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
招募中2 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- 還有 15 項
Targeted Pediatric High-Grade Glioma Therapy
招募中觀察性研究
- Nationwide Children's Hospital, Columbus
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
招募中2 期
- The Ohio State University College of Medicine (OSUCOM), Columbus
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Nationwide Children's Hospital, Columbus
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
招募中2 期
- Nationwide Children's Hospital, Columbus
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
招募中1/2 期
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Nationwide Children's Hospital, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- Ohio State University Comprehensive Cancer Center, Columbus
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
招募中1/2 期
- Ohio State University Comprehensive Cancer Center, Columbus
其他城市的 腦瘤 試驗
- Houston, TX35 項研究
- Boston, MA28 項研究
- New York City, NY25 項研究
- Washington, DC20 項研究
- Los Angeles, CA16 項研究
- Miami, FL15 項研究
- Durham, NC14 項研究
- St. Louis, MO12 項研究
- Cleveland, OH11 項研究
- Seattle, WA11 項研究
- Rochester, MN11 項研究
- Baltimore, MD11 項研究
Columbus 的其他研究
- 非小細胞肺癌56 項研究
- 乳癌39 項研究
- 卵巢癌39 項研究
- 癌症（所有類型）38 項研究
- 肺癌37 項研究
- 急性髓系白血病35 項研究
- 慢性淋巴性白血病28 項研究
- 轉移性癌症27 項研究
- 子宮內膜癌25 項研究
- 大腸直腸癌24 項研究
- 前列腺癌24 項研究
- 多發性骨髓瘤24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。